blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2486916

EP2486916 - Human growth hormone formulations [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.02.2016
Database last updated on 03.09.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BG, CY, HU, MT, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
Ajinomoto Althea, Inc.
11040 Roselle Street
San Diego, CA 92121 / US
[2015/07]
Former [2012/33]For all designated states
Althea Technologies, Inc.
11040 Roselle Street
San Diego, CA 92121 / US
Inventor(s)01 / Bush, Lawrence
1905 N 47th St.
Seattle, Washington 98103 / US
02 / Pechenov, Sergey
99 Florence Street 607
Malden, Massachusetts 02148 / US
03 / Basu, Sujit K
38 Lovett Road
Newton, Massachusetts 02459 / US
04 / Chung, Wen-Li
2285 Bunker Hill Drive
San Matteo, CA 94402 / US
 [2014/49]
Former [2014/46]01 / Bush, Lawrence
1905 N 47th St.
Seattle, Washington 98103 / US
02 / Pechenov, Sergey
99 Florence Street 607
Malden, Massachusetts 02148 / US
03 / Basu, Sujit K
38 Lovett Road
Newton, Massachusetts 02459 / US
04 / Chung, Wen-Li
2285 Bunker Hill Drive
San Matteo, CA 994402 / US
Former [2012/33]01 / Bush, Lawrence
1905 N 47th St.
Seattle, Washington 98103 / US
02 / Pechenov, Sergey
99 Florence Street 607
Malden, Massachusetts 02148 / US
03 / Basu, Sujit K
38 Lovett Road
Newton, Massachusetts 02459 / US
Representative(s)Graf von Stosch, Andreas, et al
Graf von Stosch
Patentanwaltsgesellschaft mbH
Prinzregentenstraße 22
80538 München / DE
[N/P]
Former [2012/33]Graf von Stosch, Andreas, et al
Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22
80538 München / DE
Application number, filing date11010051.813.12.2007
[2012/33]
Priority number, dateUS20060870605P18.12.2006         Original published format: US 870605 P
[2012/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2486916
Date:15.08.2012
Language:EN
[2012/33]
Type: A8 Corrected patent application 
No.:EP2486916
Date:27.03.2013
[2013/13]
Type: B1 Patent specification 
No.:EP2486916
Date:01.04.2015
Language:EN
[2015/14]
Search report(s)(Supplementary) European search report - dispatched on:EP16.07.2012
ClassificationIPC:A61K9/10, A61K38/27, A61K47/48, C07K14/61
[2012/33]
CPC:
A61K9/0019 (EP,US); A61K38/27 (EP,US); A61K47/645 (EP,US);
A61K47/6921 (EP,US); A61P5/00 (EP); A61P5/06 (EP);
C07K14/61 (EP,US); A61K47/34 (EP,US); A61K9/0021 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/33]
TitleGerman:Formulierungen menschlicher Wachstumshormone[2012/33]
English:Human growth hormone formulations[2012/33]
French:Formules d'hormone à croissance humaine[2012/33]
Examination procedure20.01.2012Examination requested  [2012/33]
13.04.2012Loss of particular rights, legal effect: Claims
28.06.2012Despatch of communication of loss of particular rights: Claims {1}
14.02.2013Amendment by applicant (claims and/or description)
15.05.2013Despatch of a communication from the examining division (Time limit: M04)
19.09.2013Reply to a communication from the examining division
09.09.2014Cancellation of oral proceeding that was planned for 18.09.2014
18.09.2014Date of oral proceedings (cancelled)
17.10.2014Communication of intention to grant the patent
19.02.2015Fee for grant paid
19.02.2015Fee for publishing/printing paid
19.02.2015Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07869230.8  / EP2120869
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070869230) is  13.06.2012
Opposition(s)05.01.2016No opposition filed within time limit [2016/10]
Fees paidRenewal fee
20.04.2012Renewal fee patent year 03
20.04.2012Renewal fee patent year 04
20.04.2012Renewal fee patent year 05
26.12.2012Renewal fee patent year 06
27.12.2013Renewal fee patent year 07
29.12.2014Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.12.2007
AT01.04.2015
BE01.04.2015
BG01.04.2015
CY01.04.2015
CZ01.04.2015
EE01.04.2015
ES01.04.2015
FI01.04.2015
IT01.04.2015
LT01.04.2015
LV01.04.2015
MC01.04.2015
MT01.04.2015
PL01.04.2015
RO01.04.2015
SI01.04.2015
SK01.04.2015
TR01.04.2015
GR02.07.2015
IS01.08.2015
PT03.08.2015
LU13.12.2015
[2017/39]
Former [2016/36]AT01.04.2015
BE01.04.2015
CZ01.04.2015
EE01.04.2015
ES01.04.2015
FI01.04.2015
IT01.04.2015
LT01.04.2015
LV01.04.2015
MC01.04.2015
PL01.04.2015
RO01.04.2015
SI01.04.2015
SK01.04.2015
GR02.07.2015
IS01.08.2015
PT03.08.2015
LU13.12.2015
Former [2016/34]AT01.04.2015
CZ01.04.2015
EE01.04.2015
ES01.04.2015
FI01.04.2015
IT01.04.2015
LT01.04.2015
LV01.04.2015
MC01.04.2015
PL01.04.2015
RO01.04.2015
SI01.04.2015
SK01.04.2015
GR02.07.2015
IS01.08.2015
PT03.08.2015
LU13.12.2015
BE31.12.2015
Former [2016/33]AT01.04.2015
CZ01.04.2015
EE01.04.2015
ES01.04.2015
FI01.04.2015
IT01.04.2015
LT01.04.2015
LV01.04.2015
MC01.04.2015
PL01.04.2015
RO01.04.2015
SI01.04.2015
SK01.04.2015
GR02.07.2015
IS01.08.2015
PT03.08.2015
BE31.12.2015
Former [2016/24]AT01.04.2015
CZ01.04.2015
EE01.04.2015
ES01.04.2015
FI01.04.2015
IT01.04.2015
LT01.04.2015
LV01.04.2015
PL01.04.2015
RO01.04.2015
SI01.04.2015
SK01.04.2015
GR02.07.2015
IS01.08.2015
PT03.08.2015
BE31.12.2015
Former [2016/21]AT01.04.2015
CZ01.04.2015
EE01.04.2015
ES01.04.2015
FI01.04.2015
IT01.04.2015
LT01.04.2015
LV01.04.2015
PL01.04.2015
RO01.04.2015
SK01.04.2015
GR02.07.2015
IS01.08.2015
PT03.08.2015
Former [2016/10]AT01.04.2015
CZ01.04.2015
EE01.04.2015
ES01.04.2015
FI01.04.2015
LT01.04.2015
LV01.04.2015
PL01.04.2015
RO01.04.2015
SK01.04.2015
GR02.07.2015
IS01.08.2015
PT03.08.2015
Former [2016/09]AT01.04.2015
CZ01.04.2015
EE01.04.2015
ES01.04.2015
FI01.04.2015
LT01.04.2015
LV01.04.2015
GR02.07.2015
IS01.08.2015
PT03.08.2015
Former [2015/51]AT01.04.2015
CZ01.04.2015
ES01.04.2015
FI01.04.2015
LT01.04.2015
LV01.04.2015
GR02.07.2015
IS01.08.2015
PT03.08.2015
Former [2015/50]CZ01.04.2015
ES01.04.2015
FI01.04.2015
LT01.04.2015
LV01.04.2015
GR02.07.2015
IS01.08.2015
PT03.08.2015
Former [2015/49]CZ01.04.2015
ES01.04.2015
FI01.04.2015
LT01.04.2015
LV01.04.2015
GR02.07.2015
PT03.08.2015
Documents cited:Search[X]WO2004060310  (ALTUS BIOLOGICS INC [US], et al) [X] 1-6,9-11,14,15,30,85,95 * paragraph [0012] - paragraph [0014] * * paragraph [0080] - paragraph [0083] * * example - * * claim - *;
 [X]WO9200998  (NOVO NORDISK AS [DK]) [X] 85,95 * examples 6-10 * * claim - *;
 [X]WO9312812  (NOVO NORDISK AS [DK]) [X] 85,95 * examples 7-10 * * claim - *;
 [XP]WO2007076131  (ALTUS PHARMACEUTICALS INC [US], et al) [XP] 1-6,9,11,14,15,30,85,95 * paragraph [0011] - paragraph [0012] * * paragraph [0043] - paragraph [0049] * * example - * * claim - *
by applicantUS4342832
 US5633352
 US2004209804
 WO2004060310
 WO2004060920
    - MAURAS ET AL., J. CLIN. ENDOCRINOLOGY AND METABOLISM, (2000), vol. 85, no. 10, pages 3653 - 3660
    - FRINDIK, HORMONE RESEARCH, (1999), vol. 51, no. 1, pages 15 - 19
    - LEGER ET AL., J. CLIN. ......... ENDOCRINOLOGY AND METABOLISM, (1998), vol. 83, no. 10, pages 3512 - 3516
    - BRAMSWIG, ENDOCRINE, (2001), vol. 15, no. L, pages 5 - 13
    - PASQUINO ET AL., HORMONE RESEARCH, (1996), vol. 46, no. 6, pages 269 - 272
    - CARROLL ET AL., TRENDS IN ENDOCRINOLOGY AND METABOLISM, (2000), vol. 11, no. 6, pages 231 - 238
    - UELAND ET AL., J. CLIN. ENDOCRINOLOGY AND METABOLISM, (2002), vol. 87, no. 6, pages 2760 - 2763
    - SIMPSON ET AL., GROWTH HORMONE & IGF RESEARCH, (2002), vol. 12, pages 1 - 33
    - MEHLS; HAAS, GROWTH HORMONE & IGF RESEARCH, (2000), vol. B, pages S31 - S37
    - FINE ET AL., J. PEDIATRICS, (2000), vol. 136, no. 3, pages 376 - 382
    - MOTOYAMA ET AL., CLIN. EXP. NEPHROLOGY, (1998), vol. 2, no. 2, pages 162 - 165
    - HIRSCHFELD, HORMONE RESEARCH, (1996), vol. 46, pages 215 - 221
    - TRITOS ET AL., AM. J. MEDICINE, (1998), vol. 105, no. 1, pages 44 - 57
    - MULLIGAN ET AL., J. PARENTERAL AND ENTERAL NUTRITION, (1999), vol. 23, no. 6, pages S202 - S209
    - TORRES; CADMAN, BIODRUGS, (2000), vol. 14, no. 2, pages 83 - 91
    - RITZEN, HORMONE RESEARCH, (2002), vol. 56, no. 5-6, page 208
    - EIHOLZER ET AL., EUR. J. PEDIATRICS, (1998), vol. 157, no. 5, pages 368 - 377
    - HARO ET AL., J. CHROMATOGRAPHY B, (1998), vol. 720, pages 39 - 47
    - BENNANI-BAITI ET AL., GENOMICS, (1995), vol. 29, pages 647 - 652
    - WU ET AL., J. CHROMATOGRAPHY, (1990), vol. 500, pages 595 - 606
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.